Rapid Micro Biosystems (RPID) Net Equity Issued and Repurchased (2020 - 2021)

Rapid Micro Biosystems (RPID) reported Net Equity Issued and Repurchased of $243000.0 for Q2 2021, down 99.09% on a YoY basis from $26.6 million in Q2 2020, and down 99.69% sequentially from $79.5 million in Q1 2021.

Rapid Micro Biosystems (RPID) Net Equity Issued and Repurchased (2020 - 2021) Analysis & Trends

Rapid Micro Biosystems (RPID) has 2 years of Net Equity Issued and Repurchased data on file, last reported at $243000.0 in Q2 2021.

  • For the quarter ending Q2 2021, Net Equity Issued and Repurchased fell 99.09% year-over-year to $243000.0; the trailing twelve-month figure through Dec 2022 stood at $243000.0 (down 99.7% YoY), and the FY2025 full-year result was $445000.0, changed N/A from the prior year.
  • Net Equity Issued and Repurchased eased to $243000.0 in Q2 2021, from $79.5 million in the prior quarter.
  • In the past five years, Net Equity Issued and Repurchased ranged from a high of $79.5 million in Q1 2021 to a low of $243000.0 in Q2 2021.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 97.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 12.70 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Rapid Micro Biosystems 90.41 Mn 80.98 Mn 371,000.00 -

Historic Data

Download Data
DateValue
Jun 30, 2021 243,000.00
Jun 30, 2021 243,000.00
Mar 31, 2021 79.50 Mn
Mar 31, 2021 79.50 Mn
Jun 30, 2020 26.64 Mn
Jun 30, 2020 26.64 Mn